Backed by over a decade of experience in expanded access, we support in the design, execution, and close-out of Expanded Access Programs (EAPs), tailored to fit any clinical program and market access strategy.
Utilize our broad experience in framework & infrastructure development, change management, and EAP strategy & program optimization.
Tap into deep expertise across regulation, reimbursement and global practical know-how, enabling compliance with country specific regulations.
Get hands-on support from our medically-trained site managers who handle all incoming requests from HCPs and streamline the entire EAP process.
Run global product distribution through our compliant (GAMP 5 Part 11) and integrated order management system.
Collaborate with our industry-leading RWD team to design, execute, and analyze your RWD projects.
Access key insights for requests, orders, and data collection through our ISO 27001-certified platform and integrated EDC system.
Steve Whitaker – Chief Medical Officer
Omeros
AiCuris team
AiCuris
At myTomorrows, we focus on four key areas to create a tailored EAP delivery plan that strategically aligns with your clinical development goals and organizational needs.
We perform a gap analysis on current processes, set up a framework and infrastructure for EAP delivery, and provide educational materials and change management support for your EAP strategy.
We help design country-specific roadmaps, timelines for program initiation, and any operational considerations, including exit strategies per target country.
We develop an EAP delivery plan that seamlessly integrates with your organization minimizing internal resource strains whilst ensuring operational excellence. Implementation is backed by our proprietary platform which includes custom reporting for full visibility.
For post-trial access, we ensure a smooth transition from clinical trials to EAP, minimizing treatment interruption. Furthermore, we facilitate the shift from EAP to licensed product, supporting your teams and patients for a timely transition.
“Being a team of medical professionals with clinical experience, we empathize with the daily challenges physicians face and highly value their time.” – Natalia Coptu, MD, Site Manager Lead – Ex-PV specialist at IQVIA.
Thank you for contacting myTomorrows! Our team will be in touch soon.
Daniele Tagliente, PharmD - Director Regulatory Affairs & Pharmacovigilance at myTomorrows